Abstract: The health benefits of eicosapentaenoic acid (EPA)-enriched phospholipids (PL) have witnessed a recent upsurge. In the present study, PL from starfish Asterias amurensis (SFP) and sea cucumber Cucumaria frondosa (SCP) were extracted and the liposomes were prepared. Both SFP and SCP liposomes showed antitumour effects in vitro and exhibited high transport and uptake effects in small intestinal epithelial cell models. The results also demonstrated that dietary SFP and SCP liposomes prolonged the life span and ameliorated oxidative stress status of S180 ascitic tumourbearing mice. Results also showed that dietary SFP and SCP liposomes up-regulated the expression of Bax and down-regulated Bcl-2 level in tumour cells, then induced release of cytochrome c from mitochondria to cytosol, thus activation of caspase 9 and caspase 3. Taken together, these findings suggest that SFP and SCP liposomes exert antitumour effects mainly via activation of mitochondrial apoptotic pathways in tumour-bearing mice.
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Abstract
The health benefits of eicosapentaenoic acid (EPA)-enriched phospholipids (PL) have witnessed a recent upsurge. In the present study, PL from starfish Asterias amurensis (SFP) and sea cucumber Cucumaria frondosa (SCP) were extracted and the liposomes were prepared. Both SFP and SCP liposomes showed antitumour effects in vitro and exhibited high transport and uptake effects in small intestinal epithelial cell models. The results also demonstrated that dietary SFP and SCP liposomes prolonged the life span and ameliorated oxidative stress status of S180 ascitic tumour-bearing mice. Results also showed that dietary SFP and SCP liposomes up-regulated the expression of Bax and down-regulated Bcl-2 level in tumour cells, then induced release of cytochrome c from mitochondria to cytosol, thus activation of caspase 9 and caspase 3. Taken together, these findings suggest that SFP and SCP liposomes exert antitumour effects mainly via activation of mitochondrial apoptotic pathways in tumour-bearing mice.
Introduction
Cancer is now the second leading cause of death in the world. Many factors influence cancer initiation and growth, including various kinds of cytokines, growth factors and oxidative stress (Colomer et al., 2007) . Oxidative stress is defined as an imbalance between production of free radicals such as reactive oxygen species (ROS) and antioxidant defenses (Reuter, Gupta, Chaturvedi, & Aggarwal, 2010) . It has been suggested that cancer initiation and progression is related to continuous oxidative stress by increasing DNA mutations and damage, genome instability and cell proliferation (Bartsch & Nair, 2006; Klaunig, Kamendulis, & Hocevar, 2010; Visconti & Grieco, 2009 ). Apoptosis, a process of programmed cell death, plays a crucial role in controlling cell proliferation and prevention of tumour development, which is characterized by morphological changes including cytoplasmic shrinkage, membrane blebbing, nuclear chromatin condensation, chromosomal DNA cleavage and nuclear fragmentation (Elmore, 2007) . Recent knowledge on apoptosis has provided the basis for novel targeted therapies that exploit apoptosis for therapeutic benefit in cancer (Rahman, Sultan, Islam, & Biomol, 2012) . Thus, agents for ameliorating oxidative stress and/or for triggering the apoptosis in cancer cells may be effective in cancer therapy.
Although conventional cancer therapies such as chemotherapy and radiotherapy can kill the cancer cells effectively, it also damages the normal cells, which often impair cancer patients` quality of life and affects the survival (Rein & Kurbacher, 2001) . Nowadays, increasing evidence from cell and animal studies indicate that dietary n-3 polyunsaturated fatty acids (PUFAs), especially eicosapentaenoic acid (EPA) can prevent carcinogenesis 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 -5 - (Larsson, Kumlin, Ingelman-Sundberg, & Wolk, 2004) . In addition, EPA supplement has been reported to be beneficial for cancer patients and without adverse effects at the recommended doses (no more than 3 grams per day) (Colomer et al., 2007) . Moreover, it has also been observed that EPA administrated in combination with different antineoplastic agents and radiotherapy can increase cancer treatment efficacy without additional side effects (Calviello, Serini, Piccioni, & Pessina, 2009 properties and the advantages of biodegradability, lack of antigenicity, and protection of encapsulated functional compounds against degradative enzymes to some extent (Hossain, Kurihara, Hosokawa, & Takahashi, 2006; Nag & Awasthi, 2013) .
Hence, in the present study, PL from starfish Asterias amurensis (SFP) and sea cucumber Cucumaria frondosa (SCP) were isolated and the liposomes composed of these PL were prepared. We determined the antitumour activity of SFP and SCP liposomes on several kinds of cancer cells. To assess the bioavailability of EPA-enriched PL, we evaluated the transport and uptake effects of SFP and SCP liposomes in small intestinal epithelial cell models. To explore the possible mechanism, we investigated the mechanisms of SFP and SCP liposomes inhibiting the tumour growth in S180 ascitic tumour-bearing mice.
Materials and Methods

Materials
The starfish Asterias amurensis were collected at the coast of Nemuro, Hokkaido, Japan.
The sea cucumber Cucumaria frondosa were purchased from aquatic product market, Qingdao, China. Soy-PL was supplied from NOF Corporation (Tokyo, Japan). Dulbecco's modified Eagle medium (DMEM), Roswell Park Memorial Institute-1640 medium (RPMI-1640), fetal bovine serum (FBS), trypsin-ethylenediaminetetraacetic acid (EDTA), non-essential amino acids (NEAA) and penicillin-streptomycin were purchased from GIBCO (Grand Island, NY, USA). 3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyl-tetrazolium bromide (MTT), acridine orange (AO) and ethidium bromide (EB) were purchased from Sigma (St.
Louis, MO, USA). Rabbit anti-Bax, Bcl-2, cytochrome c, cleaved-caspase 9, cleaved-caspase 3 and β-actin polyclonal antibodies, and goat-anti rabbit antibody IgG-horseradish peroxidase (HRP) were from Cell Signaling Technology (Beverly, MA, USA).
Preparation of phospholipids from starfish and sea cucumber
The phospholipids were extracted from the gonad and viscera of starfish as well as the body wall of sea cucumber following the modified method of Liu et al. (2014) . Just in brief, extracted total lipids were applied to a silica gel column chromatography and eluted with chloroform, acetone and then methanol sequentially. Finally, the methanol eluent was collected and evaporated to obtain the phospholipids. The purity of phospholipids were confirmed to be 94.5 % (SFP) and 93.7 % (SCP) conducted by normal phase high 
Fatty acid composition analysis of phospholipids
The phospholipids were converted to methyl ester derivatives following the method of Prevot and Mordret (Prevot & Mordret, 1976 ) with slight modifications. The dried sample was dissolved in n-hexane and 0.2 mL 2 M methanolic-NaOH was added. Then, the mixture was shaken, kept at 50 °C for 30 seconds and 0.2 mL 2 M HCl in methanol was added and shaken to neutralize. The mixture was separated by centrifugation at 700 ×g for 5 minutes.
The upper n-hexane layer was collected, concentrated, and subjected to gas chromatographic 
Preparation of liposomes
The liposomes were prepared following the method of Bangham (Bangham, Standish, & Watkins, 1965) . The mixing molar ratios of the composite lipid classes were SFP/cholesterol = 1:1 (mol/mol), SCP/cholesterol = 1:1 (mol/mol) and soy-PL/cholesterol = 1:1 (mol/mol). -8 -vigorous vortex mixing for 5 min and were then extruded 21 times through polycarbonate membrane filter (Whatman Inc., Newton, MA, USA) with pore size of 200 nm. The size distribution of liposomes were determined using a dynamic light scattering particle size analyzer LB-500 (HORIBA, Kyoto, Japan). The S180, HepG2 and HeLa cells were grown in RPMI-1640 medium, supplemented with 10 % heat-inactivated FBS, 100 U/mL penicillin and 100 μg/mL streptomycin at 37 °C in a humidified atmosphere containing 5 % CO 2 . P388 cells were cultured in DMEM medium with 100 U/mL penicillin, 100 µg/mL streptomycin and 10 % heat-incubated FBS.
Cell Culture
The Caco-2 cells were grown in DMEM with 100 U/mL penicillin, 100 µg/mL streptomycin, 1 % NEAA, and 10 % heat-incubated FBS at 37 °C in a 5 % CO 2 -humidified incubation. Raji cells were cultured in RPMI 1640 medium with 100 U/mL penicillin, 100 µg/mL streptomycin, 1 % NEAA and 10 % heat-incubated FBS. 
Establishment and validation the small intestinal epithelial cell models
For Caco-2 cell monolayer model, caco-2 cells were seeded at a density of 3 × 10 4 cells/mL onto a 12 mm polycarbonate transwell filter insert with 3.0 m pores and a surface area of 0.6 cm 2 (Millipore Co. Ltd., Billerica, MA, USA). The transwell filter inserts were placed in 24-well cell culture plates. The cells were grown with 400 µL DMEM in the apical (AP) chamber and 600 µL DMEM in the basolateral (BL) chamber. The AP and BL chamber were given fresh DMEM at two-day intervals until use. Caco-2 cells were grown for 20 days (postconfluence) before the experiments.
For microfold cell (M cell) monolayer model, the incubaton of M cells from caco-2 cells was performed accoding to the methods of Gullberg et al. (2000) . Briefly, 5×10 5 cells/mL raji 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 -10 -cells were resuspended in RPMI/DMEM (1:2, v/v) mixture medium and added to the BL chamber of 14-day-old Caco-2 cell monolayer. The cocultures were maintained for another 6 days.
To verify the monolayer integrity, the transepithelial electrical resistance (TEER) was measured using a Millicell ® ERS (Billerica, MA, USA). The full differentiation of M cell monolayer was confirmed by checking the amount of engulfed fluorescent latex beads (Murakawa et al., 2007) .
Transport and uptake studies of liposomes
Before each experiment, the AP chamber and BL chamber were washed twice and pre-equilibrated for 30 min in Hanks balanced salt solution (HBSS) containing 10 mM MES and 1 % FBS at pH 6.0 in the AP chamber and HBSS containing 10 mM HEPES and 1 % FBS at pH 7.4 in the BL chamber. One mM calcein encapsulated liposomes in 400 µL HBSS (pH 6.0) was added to the AP chamber while the BL chamber contained 600 µL HBSS at pH 7.4. After incubation at 37 °C for 2 h, the HBSS in the BL chamber was collected and 10 % Triton X-100 was added to disrupt the transported liposomes. Then, cells were washed by PBS, harvested and lysed. The fluorescent intensity was determined using Hitachi F-2500 fluorescence spectrophotometer (Hitachi Co. Ltd., Ibaraki, Japan). The excitation and emission wavelengths were 490 and 520 nm, respectively. S180 cells (1×10 6 cells in 0.2 mL PBS) were injected into the KM mice via abdominal cavity. The mice were then randomly divided into three groups (8 mice in each group): model control group, SFP-treated and SCP-treated group. After 24 h, the animals in each group were given intragastrically of normal saline, SFP or SCP liposomes (100 mg/kg BW) once per day for totally 14 consecutive days. After the final drug administration, the mice were allowed free access to water and food until death and then calculated the survival rate.
Experiment 2
S180 ascitic tumour-bearing mice model was established as Experiment 1 described.
After inoculated tumour cells, the mice were randomly divided into four groups (8 mice in each group): normal control group, model control group, SFP-treated and SCP-treated group.
After 24 h, the mice were given intragastrically of normal saline, SFP or SCP liposomes (100 mg/kg BW) once per day for 14 days. At day 15, the mice of each group were sacrificed. The ascitic fluid in each group were collected and weighed. A portion of ascitic tumour in each group was placed in nuclease-free tubes and dissolved in Trizol reagent to extract total RNA and the other portion was used for AO and EB staining. The viable tumour cells counts were measured. Liver were quickly excised, rinsed in ice-cold normal saline, then were snap-frozen in liquid nitrogen and stored at -80 °C until analysis.
Analysis of biochemical parameters in liver
Prior to biochemical analysis, each liver sample (100 mg/mL buffer) was homogenized in 50 mM phosphate buffer (pH 7.0) under ice bath condition. 
Cellular morphological analysis of apoptosis
Morphological changes in the nuclear chromatin of cells undergoing apoptosis were detected by fluorescence microscopy using AO and EB staining. The ascitic tumour cells in each group were harvested, centrifuged, washed and appropriately diluted with phosphate buffered saline (PBS). The 20 μL of diluent cell suspension was stained with 100 μg/mL AO   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 -13 -and 100 μg/mL EB for 10 min at room temperature. Cells were then observed by fluorescent microscope (IX-51, Olympus, Tokyo, Japan) equipped with an automatic photomicrograph system.
Real-time polymerase chain reaction analysis
Total RNA was extracted from the S180 ascitic tumour cells using Trizol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacture's recommended procedures.
One microgram RNA was converted to first strand cDNA using MMLV reverse transcriptase accomplished using an endogenous reference β-actin. A dilution curve from one cDNA source using dilutions of 1:2, 1:4, 1:8 and a no-template control was run for each gene. The gene expression level was analyzed by relative quantification using the standard curve method.
Primer sequences are described in Table 1 .
Western blotting analysis
For western blotting analysis, S180 ascitic tumour cells were lysed in ice-cold RIPA lysis buffer to obtain cellular protein. For isolation of mitochondrial and cytosolic fractions, the Mitochondria/Cytosol Fractionation Kit (BioVision Inc., Milpitas, CA, USA) was used.
The proteins were separated by 10% sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to polyvinylidene fluoride (PVDF) membranes.
The membranes were blotted with Tris-Hcl buffered buffer saline (TBS) containing 1 % Tween 20 (TBST) and 5 % non-fat milk for 2 h, and then incubated with Bax, Bcl-2, cytochrome c, cleaved-caspase 9, cleaved-caspase 3 or β-actin primary antibodies (diluted 1:1000) at 4 °C overnight. After washing with TBST for 5 times, membranes were incubated with IgG-HRP secondary antibodies at room temperature for 1 h. The bands were detected by using an enhanced chemiluminesence kit (Applygen, Beijing, China). Normalization of protein expression was carried out using β-actin as control.
Statistical analysis
All the values in this study are expressed as mean ± standard error of the mean (SEM).
All statistical analyses were performed using SPSS software. Data were analyzed using Tukey's post hoc test. P value less than 0.05 was considered statistically significant. 
Results
Fatty acid composition of phospholipids
Fatty acid compositions of phospholipids extracted from starfish, sea cucumber and soy are shown in Table 2 . SFP contained 42 % EPA (C20:5), 8.8 % arachidonic acid (AA) and 6.8 % docosahexaenoic acid (DHA, C22:6) while SCP included 47.9 % EPA, 11.5 % stearic acid (C18:0) and 6.1 % oleic acid (C18:1). The major fatty acids in soy-PL were linoleic acid (C18:2, 62.7 %), palmitic acid (C16:0, 18.9 %) and oleic acid (9.7 %).
Effects of SFP and SCP liposomes on proliferation of cancer cells in vitro
The inhibitory effects of SFP and SCP liposomes against several kinds of cancer cells were measured by colorimetric MTT assay. As shown in Fig. 1 , both SFP and SCP liposomes showed a dose-dependent inhibitory effects on the viability of S180, P388, HepG2 and HeLa cells. The IC 50 value of SFP and SCP liposomes on S180 cells at 72 h were 198.5 μM and 187.5 μM, respectively. These results indicate that SFP and SCP liposomes exert anti-proliferative activity against several kinds of cancer cells.
Effects of phospholipids liposomes on transport and uptake in small
intestinal epithelial cell models.
To assess the absorption of SFP and SCP liposomes, we established the small intestinal epithelial cell models and evaluated the transport and uptake effects of SFP and SCP liposomes. Prior to transport and uptake studies, the monolayer integrity of small intestinal epithelial cell models (Caco-2 cell monolayer model and M cell monolayer model) were 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 The phospholipids liposomes transport through the Caco-2 or M cell monolayer model was measured by the transported calcein amount encapsulated in the liposomes. The average particle sizes of calcein encapsulated liposomes of SFP, SCP and soy-PL were 168.9 ± 34.4, 174.2 ± 38.6 and 169.1 ± 34.8 nm, respectively. As shown in Fig. 2 , the phospholipids liposomes exhibited significantly higher transport in M cell monolayer model. In addition, the transport and uptake of SFP and SCP liposomes were potently higher than soy-PL liposomes in both Caco-2 and M cell monolayer models. These data suggest that the liposomes composed of n-3 PUFAs largely promote the absorption of those liposomes through small intestinal epithelial cells.
Antitumour effects of SFP and SCP liposomes in S180 ascitic tumour-bearing mice
To better understand the antitumour activity of SFP and SCP liposomes in vivo, we employed the S180 ascitic tumour-bearing mice model and evaluated the mean survival time of tumour-bearing mice after treated with SFP or SCP liposomes. As shown in Fig. 3 & Table 3 , the mean survival time of model control group was 14.8 ± 0.88 days, while the mice treated with SFP and SCP liposomes (100 mg/kg BW) prolonged the survival time to 19.9 ± 1.33 days (P < 0.01) and 20.1 ± 0.74 days (P < 0.01). To quantify the antitumour effects of SFP and SCP liposomes on S180 ascitic tumourbearing mice, the ascitic fluid weight and tumour cells viability in mice were measured and calculated at day 15. As shown in Fig. 4 , significant reductions in S180 ascitic fluid weight were observed in SFP-treated and SCP-treated mice as compared to the tumour model group.
Moreover, the ascitic tumour cell viability in mice after dietary SFP and SCP liposomes for 14 days also decreased notably (Fig. 4) . These findings suggest that SFP and SCP liposomes also exhibit potent antitumour activity in vivo.
Effects of SFP and SCP liposomes on hepatic biochemical parameters in mice
Continuous oxidative stress can lead to chronic inflammation and cause most chronic diseases such as cancer. To investigate whether SFP and SCP liposomes ameliorate the oxidative stress status in S180 ascitic tumour-bearing mice, GSH content and the activities of SOD and CAT in liver were determined. Inoculation of S180 tumour cells in mice drastically decreased hepatic GSH content and inhibited hepatic SOD and CAT activities. Oral administration of SFP and SCP liposomes at 100 mg/kg BW could partly recover GSH content, SOD and CAT activities in the liver of S180 ascitic tumour-bearing mice (Fig. 5) .
These results reveal that the antitumour activity of SFP and SCP liposomes may be partly attributed to their antioxidant properties.
Effects of SFP and SCP liposomes on induction of ascitic tumour cells apoptosis
To ascertain whether SFP and SCP liposomes inhibit cell proliferation of S180 ascitic tumour cells by inducting apoptosis, the cellular morphological changes of S180 ascitic tumour cells treated with SFP and SCP liposomes were evaluated using fluorescence microscopy after staining S180 ascitic tumour cells with AO and EB. Images manifested that the viable tumour cells with normal morphology stained bright green (arrow 1) were observed in model control group (Fig. 6A) , while the later apoptotic tumour cells with condensed and fragmented chromatin as well as apoptotic bodies (arrow 2 and 3) stained bright orange were exhibited after treatment of SFP or SCP liposomes ( Fig. 6B and 6C) . These results suggest that SFP and SCP liposomes would induce apoptosis of S180 ascitic tumour cells.
Effects of SFP and SCP liposomes on expression of apoptosis-related factors
Finally, to further clarify whether the mitochondrial apoptotic pathways are involved in SFP and SCP-induced apoptosis, the mRNA or protein expression of pro-apoptotic factors such as Bax, cytochrome c, caspase 9, cleaved-caspase 9, caspase 3 and cleaved-caspase 3 as well as anti-apoptotic factor Bcl-2 were investigated. As shown in Fig. 7 and Fig. 8 , the mRNA expression of Bax in S180 ascitic tumour cells were increased significantly with SFP and SCP liposomes treatment (by 2.3 and 2.1 fold) as compared to the tumour model group.
Moreover, SFP and SCP liposomes also elevated the Bax protein expression by 2.1 and 2.9 fold (P < 0.01). On the other hand, after treatment with SFP and SCP liposomes at 100 mg/kg BW in tumour-bearing mice, the mRNA expression of Bcl-2 were highly down-regulated by   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 -19 -45.7 % and 48.1 % in comparison to the model control group. Furthermore, western blotting assay showed that SFP and SCP liposomes also significantly decreased the Bcl-2 protein expression by 29.5 % and 39.3 % (P < 0.01). The imbalance of Bax/Bcl-2 ratio leads to the damage of mitochondrial membrane and the release of cytochrome c from the mitochondrial intermembrane into the cytosol. Therefore, we also determined the cytochrome c protein level in mitochondria and cytosol of S180 ascitic tumour cells. As we expected, SFP and SCP liposomes decreased the protein levels of cytochrome c in mitochondria notably, whereas increased the cytochrome c protein expression in cytosol as compared with model control group. Our findings also found that dietary SFP and SCP liposome increased the mRNA levels of caspase 9 (by 1.8 and 1.7 fold) and caspase 3 (by 2 and 1.8 fold) remarkably (P < 0.01). In addition, the protein levels of cleaved-caspase 9 and cleaved-caspase 3 in S180 ascitic tumour cells were also elevated significantly after treated with SFP and SCP liposomes.
These findings reveal that SFP and SCP-induced apoptosis may be mediated via activation of mitochondrial apoptotic pathways.
Discussion
In the present study, our findings manifested that liposomes composed of EPA-enriched phospholipids extracted from starfish and sea cucumber exhibited potent antitumour effects on several kinds of cancer cells and S180 ascitic tumour-bearing mice.
It is now well known that liposomes which are mainly composed of PL have biological and technological advantages as optimal delivery systems for biological substances (Bozzuto & Molinari, 2015) . PL is poorly soluble in water or culture medium, therefore the liposomes 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 -21 -In S180 ascitic tumour-bearing mice, a rapid increase in ascitic fluid with tumour cells growth and high early mortality rate were observed. Dietary SFP and SCP liposomes prolonged the life span of tumour-bearing mice. It has been suggested that the agent whether prolongs the life span of tumour-bearing animals is considered as a major indicator to evaluate its antitumour activity (Gupta et al., 2004) . In addition, we also found that oral treatment of SFP and SCP liposomes decreased the ascitic fluid volume and the ascitic tumour cells viability in tumour-bearing mice. It may be concluded that SFP and SCP liposomes increase the life span of S180 ascitic tumour-bearing mice via decreasing ascitic fluid volume and killing ascitic tumour cells.
A wealth of studies report that excessive production of free radicals will result in oxidative stress and continuous oxidative stress can lead to chronic inflammation, which is associated with an increased risk of several kinds of cancer (Gupta et al., 2004; Klaunig et al., 2010) . High concentration of GSH is found in the liver and it is considered to play an important role in the endogenous antioxidant system. In addition, enzymatic antioxidant defense mechanisms are considered to be responsible for the elimination of free radicals such as superoxide and hydrogen peroxide. SOD catalyzes the dismutation of superoxide into hydrogen peroxide, which has to be eliminated by CAT (Gupta et al., 2004) . It has been reported that a decrease in GSH content as well as SOD and CAT activities are observed in the liver of tumour-bearing mice (Alam, Majumder, Akter, & Lee, 2015; Ray et al., 2014) .
And inhibition of antioxidant enzyme activities also occur in cancer patients (Tu et al., 2014) .
Previous studies have shown that dietary fish oil up-regulates the genes coding of some antioxidant enzymes such as SOD in mice, suggesting the protective effect against the production of ROS and thus against tumour growth (Takahashi et al., 2002) . Moreover, it has also been proved that the continual consumption of EPA plus DHA significantly decreased the ROS levels in the plasma of patients with advanced inoperable non-small cell lung cancer (Finocchiaro et al., 2012) . Consistent with this, similar findings were observed in the present study. Oral administration of SFP and SCP liposomes significantly restored GSH levels as well as SOD and CAT activities in the liver of S180 ascitic tumour-bearing mice as compared to the model control group, suggesting that antitumour properties of SFP and SCP liposomes may also be partly attributed to their potent antioxidant activities. However, others have reported that EPA was found to suppress the cancer cell growth by its formation of oxidation products, which leads to apoptosis and cell growth (Larsson et al., 2004) . These disparities could be explained because lipid peroxidation of EPA in vivo may not correspond with that in vitro. On the other hand, inflammation has been hypothesized to increase the production of free radicals and ROS, which leads to carcinogenesis. However, n-3 fatty acids such as EPA can ameliorate inflammation and thus decrease the production of free radicals in vivo.
The observation of AO and EB staining indicated that SFP and SCP liposomes killed S180 ascitic tumour cells via induction of apoptosis. Apoptosis is a complex biological process involving many pathways, which has been a potential target for novel therapeutic molecules. The members of Bcl-2 family are considered as one of the most important regulators of the mitochondrial pathways of apoptosis (Wang et al., 2006) . Bcl-2 family contains pro-apoptotic genes such as Bax and anti-apoptotic genes such as Bcl-2 .   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 -23 -Pro-apoptotic gene Bax acts as a promoter of apoptosis while anti-apoptotic gene Bcl-2 serves as a repressor (Elmore, 2007) . The Bax/Bcl-2 ratio regulates the apoptosis by controlling the integrity of the outer mitochondrial membrane. As mentioned above, the imbalance of Bax/Bcl-2 ratio leads to the damage of mitochondrial membrane and the release of cytochrome c from the mitochondrial intermembrane into the cytosol. The released cytochrome c in cytosol then activates initiator caspases, which cleave a number of cellular protein to cause apoptotic changes. Caspase 9, one of the upstream caspases in apoptosis signaling cascades and its activation is normally required for executioner caspases activation.
Caspase 3, the critical executioner caspases of apoptosis, is activated by initiator caspases, ultimately resulting in apoptosis (Elmore, 2007; Lowe, 2000; Rahman et al., 2012; . Studies have suggested that EPA induced apoptosis in esophageal squamous cell carcinoma and HepG2 cells through mitochondrial pathways (Mizoguchi et al., 2014; . In this study, our data revealed that the mRNA and protein expression of pro-apoptotic gene Bax was up-regulated, whereas the anti-apoptotic factor Bcl-2 was down-regulated in S180 ascitic tumour cells after treated with SFP or SCP liposomes. As a consequence of these changes, the Bax/Bcl-2 ratio was significantly increased, which induced the decrease of cytochrome c protein level in mitochondria and increase of the cytochrome c protein expression in cytosol. And the up-regulations of caspase 9 and caspase 3 mRNA levels as well as cleaved-caspase 9 and cleaved-caspase 3 protein expression in tumour cells were also observed in the SFP and SCP liposomes-treated group. These findings imply that the mechanism of SFP and SCP liposomes in inducing apoptosis of S180 ascitic tumour cells must involve activation of mitochondrial apoptotic pathways.
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Table 3
The mean survival time of S180 ascitic tumour-bearing mice. S180 cells (10 6 cells/mouse)
were injected intraperitoneally into mice. After 24 hours, the mice in each group (n=8) were administered intragastrically with normal saline (NS), SFP or SCP liposomes (100 mg/kg BW) for totally 14 consecutive days. After the final drug administration, the mice were allowed free access 
Fig. 3
Survival curve of SFP and SCP liposomes in S180 ascitic tumour bearing-mice. S180 cells (10 6 cells/mouse) were injected intraperitoneally into mice. After 24 hours, the mice in each group (n=8) were administered intragastrically with normal saline, SFP or SCP liposomes (100 mg/kg BW) for totally 14 consecutive days. After the final drug administration, the mice were allowed free access to water and food until death. The survival rate was followed up to 24 days after inoculation. The S180 ascitic tumour bearing-mice in each group (n=8) were administered intragastrically with normal saline, SFP or SCP liposomes (100 mg/kg BW) for 14 days. The ascitic fluid 
